Mounjaro Beats Ozempic for Weight Loss in Early Trial
WEDNESDAY, Nov. 29, 2023 (Healthday News) — The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report. Both Mounjaro (tirzepatide) and Ozempic (semaglutide) mimic the effects of the gut hormone GLP-1, which triggers insulin production, helps control appetiteContinue Reading